Vertero Therapeutics, Inc.
Founded 2016 · 12 employees on LinkedIn · 2 known investors
Vertero develops therapies for neurodegenerative diseases by targeting causative mechanisms in the peripheral nervous system rather than addressing symptoms alone. The company uses discoveries in microbiology, pharmacology, and neuroscience to create novel drug treatments for patients with unmet needs.
Founders & leadership
Vertero Therapeutics, Inc. was founded in 2016 by Sarkis Mazmanian, PhD.
SM
Sarkis Mazmanian, PhDCo-founder and Board Member
Investors · 2
Frequently asked questions
- What does Vertero Therapeutics, Inc. do?
- Vertero develops therapies for neurodegenerative diseases by targeting causative mechanisms in the peripheral nervous system rather than addressing symptoms alone. The company uses discoveries in microbiology, pharmacology, and neuroscience to create novel drug treatments for patients with unmet needs.
- Who founded Vertero Therapeutics, Inc.?
- Vertero Therapeutics, Inc. was founded by Sarkis Mazmanian, PhD in 2016.
- Who are Vertero Therapeutics, Inc.'s investors?
- Vertero Therapeutics, Inc.'s investors include Taiho Ventures, LLC, UTokyo Innovation Platform Co. Ltd..